1. Home
  2. HTBK vs SVRA Comparison

HTBK vs SVRA Comparison

Compare HTBK & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTBK
  • SVRA
  • Stock Information
  • Founded
  • HTBK 1997
  • SVRA 2007
  • Country
  • HTBK United States
  • SVRA United States
  • Employees
  • HTBK N/A
  • SVRA N/A
  • Industry
  • HTBK Major Banks
  • SVRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTBK Finance
  • SVRA Health Care
  • Exchange
  • HTBK Nasdaq
  • SVRA Nasdaq
  • Market Cap
  • HTBK 588.2M
  • SVRA 528.3M
  • IPO Year
  • HTBK 1998
  • SVRA N/A
  • Fundamental
  • Price
  • HTBK $10.29
  • SVRA $2.32
  • Analyst Decision
  • HTBK Buy
  • SVRA Buy
  • Analyst Count
  • HTBK 3
  • SVRA 5
  • Target Price
  • HTBK $11.33
  • SVRA $5.60
  • AVG Volume (30 Days)
  • HTBK 481.2K
  • SVRA 1.4M
  • Earning Date
  • HTBK 07-24-2025
  • SVRA 08-11-2025
  • Dividend Yield
  • HTBK 4.99%
  • SVRA N/A
  • EPS Growth
  • HTBK N/A
  • SVRA N/A
  • EPS
  • HTBK 0.68
  • SVRA N/A
  • Revenue
  • HTBK $174,083,000.00
  • SVRA N/A
  • Revenue This Year
  • HTBK $7.71
  • SVRA N/A
  • Revenue Next Year
  • HTBK $6.13
  • SVRA N/A
  • P/E Ratio
  • HTBK $15.32
  • SVRA N/A
  • Revenue Growth
  • HTBK N/A
  • SVRA N/A
  • 52 Week Low
  • HTBK $8.09
  • SVRA $1.89
  • 52 Week High
  • HTBK $11.27
  • SVRA $5.03
  • Technical
  • Relative Strength Index (RSI)
  • HTBK 65.39
  • SVRA 55.49
  • Support Level
  • HTBK $10.34
  • SVRA $2.24
  • Resistance Level
  • HTBK $10.52
  • SVRA $2.50
  • Average True Range (ATR)
  • HTBK 0.21
  • SVRA 0.16
  • MACD
  • HTBK 0.02
  • SVRA 0.06
  • Stochastic Oscillator
  • HTBK 71.19
  • SVRA 83.03

About HTBK Heritage Commerce Corp

Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two reportable segments, namely Banking and Factoring. A majority of its revenue is generated from the Banking segment, which provides various loan products, including commercial and industrial loans, commercial real estate loans, construction loans, etc. This segment also focuses on deposit generation on relationship accounts, encompassing non-interest bearing demand, interest bearing demand, money market accounts, certificates of deposit, and savings accounts.

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

Share on Social Networks: